-

AIS Healthcare Celebrates 15-Year Anniversary of Providing Quality Care to Patients

Targeted Drug Delivery and Infusion Care Solutions Provider Commemorates Milestone of Providing Patient-Centered Care

DALLAS--(BUSINESS WIRE)--AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, celebrates fifteen years of delivering high quality patient care. Established in 2008 in Dallas, Texas, AIS Healthcare has grown to eight locations across six states supporting more than 35,000 patients throughout the country. The company’s state-of-the-art compounding pharmacies and highly trained pharmacists produce medications of the highest quality and sterility that enhance patient quality of life and lead to better outcomes.

“For the past fifteen years, AIS Healthcare has delivered care and support for our patients that makes their days easier and lives better. We go beyond what is expected to set higher quality standards for targeted drug delivery and infusion care, enabling an improved quality of life for our patients,” said Simon Castellanos, AIS Healthcare Chief Executive Officer. “AIS Healthcare looks forward to continuing the important work of improving the lives of the patients and physicians we serve.”

AIS Healthcare compounds patient-specific prescriptions at its state-of-the-art 503A specialty pharmacies for its targeted drug delivery (TDD) division and provides personalized services for both patients and physicians. Utilizing AIS Healthcare’s TDD medication and services helps patients better manage chronic pain and spasticity to improve daily functionality.

Additionally, AIS Healthcare’s Advanced Infusion Care (AIC) division offers a comprehensive suite of services for patients with complex medical conditions like primary immunodeficiency and is supported by its team of highly trained nurses. AIC applies a team-based approach to intravenous and subcutaneous immunoglobulin therapy patient care with locations in Mississippi, Alabama, Georgia, Texas, Florida and Maryland.

AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers. As the industry leader in targeted drug delivery and infusion care, AIS Healthcare continues to deliver transformative services across the care continuum for its patients.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com

Contacts

Simon Castellanos
877.443.4006

AIS Healthcare


Release Versions

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

AIS Healthcare Recognized with URAC Leader in Performance Measurement Award

DALLAS--(BUSINESS WIRE)--AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it has been named a 2024 Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program. This is the second year in a row that AIS Healthcare has been recognized as a Pioneer by URAC for promoting trust in the quality of care delivered through performance measurement activities. To be recognized with the Pioneer in Performance Measu...

Advanced Infusion Care (AIC) now offers GC Biopharma’s ALYGLO™ [Immune Globulin Intravenous (Human-stwk) 10% liquid]

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID). The nationally accredited home infusion teams at AIC collaborate c...

AIS Healthcare Supports Physicians and Patients Impacted by Hurricanes Helene and Milton

DALLAS--(BUSINESS WIRE)--In response to recent hurricanes that devastated many communities across the Southeastern United States, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is providing additional support to physicians and patients to ensure continuity of care and access to life-saving medication. The destruction of critical infrastructure and extended power outages have created acute challenges for patients who rely on timely delivery and su...
Back to Newsroom